Dissociation of amyloid biomarkers in PET and CSF in Alzheimer’s disease: a case report
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2377
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Dissociation of amyloid biomarkers in PET and CSF in Alzheimer’s disease: a case report ; volume:15 ; number:1 ; day:26 ; month:8 ; year:2015 ; pages:1-4 ; date:12.2015
BMC neurology ; 15, Heft 1 (26.8.2015), 1-4, 12.2015
- Urheber
-
Schroeter, Matthias L.
- Beteiligte Personen und Organisationen
-
Tiepolt, Solveig
Marschhauser, Anke
Thöne-Otto, Angelika
Hoffmann, Karl-Titus
Barthel, Henryk
Obrig, Hellmuth
Sabri, Osama
SpringerLink (Online service)
- DOI
-
10.1186/s12883-015-0410-5
- URN
-
urn:nbn:de:1111-2016110510892
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Schroeter, Matthias L.
- Tiepolt, Solveig
- Marschhauser, Anke
- Thöne-Otto, Angelika
- Hoffmann, Karl-Titus
- Barthel, Henryk
- Obrig, Hellmuth
- Sabri, Osama
- SpringerLink (Online service)
Ähnliche Objekte (12)
Decreased CSF clearance and increased brain amyloid in Alzheimer’s disease
Alzheimer’s disease CSF biomarkers: clinical indications and rational use
Blood Derived Amyloid Biomarkers for Alzheimer’s Disease Prevention
CSF level of β-amyloid peptide predicts mortality in Alzheimer’s disease
Multiplex proteomics identifies novel CSF and plasma biomarkers of early Alzheimer’s disease
Bile acid profile associated with CSF and PET biomarkers in Alzheimer’s disease
CSF complement 3 and factor H are staging biomarkers in Alzheimer’s disease
Diagnosis of Alzheimer’s disease utilizing amyloid and tau as fluid biomarkers
Cortical folding correlates to aging and Alzheimer’s Disease’s cognitive and CSF biomarkers
No diurnal variation of classical and candidate biomarkers of Alzheimer’s disease in CSF
A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood
Neuroimaging biomarkers and CSF sTREM2 levels in Alzheimer’s disease: a longitudinal study
Decreased CSF clearance and increased brain amyloid in Alzheimer’s disease
Alzheimer’s disease CSF biomarkers: clinical indications and rational use
Blood Derived Amyloid Biomarkers for Alzheimer’s Disease Prevention
CSF level of β-amyloid peptide predicts mortality in Alzheimer’s disease
Multiplex proteomics identifies novel CSF and plasma biomarkers of early Alzheimer’s disease
Bile acid profile associated with CSF and PET biomarkers in Alzheimer’s disease
CSF complement 3 and factor H are staging biomarkers in Alzheimer’s disease
Diagnosis of Alzheimer’s disease utilizing amyloid and tau as fluid biomarkers
Cortical folding correlates to aging and Alzheimer’s Disease’s cognitive and CSF biomarkers
No diurnal variation of classical and candidate biomarkers of Alzheimer’s disease in CSF
A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood
Neuroimaging biomarkers and CSF sTREM2 levels in Alzheimer’s disease: a longitudinal study
Decreased CSF clearance and increased brain amyloid in Alzheimer’s disease
Alzheimer’s disease CSF biomarkers: clinical indications and rational use
Blood Derived Amyloid Biomarkers for Alzheimer’s Disease Prevention
CSF level of β-amyloid peptide predicts mortality in Alzheimer’s disease
Multiplex proteomics identifies novel CSF and plasma biomarkers of early Alzheimer’s disease
Bile acid profile associated with CSF and PET biomarkers in Alzheimer’s disease
CSF complement 3 and factor H are staging biomarkers in Alzheimer’s disease
Diagnosis of Alzheimer’s disease utilizing amyloid and tau as fluid biomarkers
Cortical folding correlates to aging and Alzheimer’s Disease’s cognitive and CSF biomarkers
No diurnal variation of classical and candidate biomarkers of Alzheimer’s disease in CSF
A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood